TABLE OF CONTENTS
|  |  |  | Volume 35, Issue 43 (October 2016) |  | In this issue Review Original Articles Short Communications
Also new    AOP | |  |  | Review | Top |  | TRIMming p53’s anticancer activityS Elabd, G Meroni and C Blattner Oncogene 2016 35: 5577-5584; advance online publication, February 22, 2016; 10.1038/onc.2016.33 Abstract | Full Text |  | Original Articles | Top |  | Cartilage oligomeric matrix protein contributes to the development and metastasis of breast cancerE Englund, M Bartoschek, B Reitsma, L Jacobsson, A Escudero-Esparza, A Orimo, K Leandersson, C Hagerling, A Aspberg, P Storm, M Okroj, H Mulder, K Jirström, K Pietras and A M Blom Oncogene 2016 35: 5585-5596; advance online publication, April 11, 2016; 10.1038/onc.2016.98 Abstract | Full Text |  |  |  | Osteocytic connexin hemichannels suppress breast cancer growth and bone metastasisJ Z Zhou, M A Riquelme, S Gu, R Kar, X Gao, L Sun and J X Jiang Oncogene 2016 35: 5597-5607; advance online publication, April 4, 2016; 10.1038/onc.2016.101 Abstract | Full Text |  |  |  | A novel association of neuropilin-1 and MUC1 in pancreatic ductal adenocarcinoma: role in induction of VEGF signaling and angiogenesisR Zhou, J M Curry, L D Roy, P Grover, J Haider, L J Moore, S-t Wu, A Kamesh, M Yazdanifar, W A Ahrens, T Leung and P Mukherjee Oncogene 2016 35: 5608-5618; advance online publication, January 25, 2016; 10.1038/onc.2015.516 Abstract | Full Text |  |  |  | All-trans retinoic acid targets gastric cancer stem cells and inhibits patient-derived gastric carcinoma tumor growthP H Nguyen, J Giraud, C Staedel, L Chambonnier, P Dubus, E Chevret, H Bœuf, X Gauthereau, B Rousseau, M Fevre, I Soubeyran, G Belleannée, S Evrard, D Collet, F Mégraud and C Varon Oncogene 2016 35: 5619-5628; advance online publication, May 9, 2016; 10.1038/onc.2016.87 Abstract | Full Text |  |  |  | Caspase-8 tyrosine-380 phosphorylation inhibits CD95 DISC function by preventing procaspase-8 maturation and cycling within the complex OPENI R Powley, M A Hughes, K Cain and M MacFarlane Oncogene 2016 35: 5629-5640; advance online publication, April 25, 2016; 10.1038/onc.2016.99 Abstract | Full Text |  |  |  | SHP-2-upregulated ZEB1 is important for PDGFRα-driven glioma epithelial–mesenchymal transition and invasion in mice and humans OPENL Zhang, W Zhang, Y Li, A Alvarez, Z Li, Y Wang, L Song, D Lv, I Nakano, B Hu, S-Y Cheng and H Feng Oncogene 2016 35: 5641-5652; advance online publication, April 4, 2016; 10.1038/onc.2016.100 Abstract | Full Text |  |  |  | Loss of Keratin 17 induces tissue-specific cytokine polarization and cellular differentiation in HPV16-driven cervical tumorigenesis in vivoR P Hobbs, A S Batazzi, M C Han and P A Coulombe Oncogene 2016 35: 5653-5662; advance online publication, April 11, 2016; 10.1038/onc.2016.102 Abstract | Full Text |  |  |  | Elimination of chronic lymphocytic leukemia cells in stromal microenvironment by targeting CPT with an antiangina drug perhexilineP-P Liu, J Liu, W-Q Jiang, J S Carew, M A Ogasawara, H Pelicano, C M Croce, Z Estrov, R-H Xu, M J Keating and P Huang Oncogene 2016 35: 5663-5673; advance online publication, April 11, 2016; 10.1038/onc.2016.103 Abstract | Full Text |  |  |  | HLJ1 is an endogenous Src inhibitor suppressing cancer progression through dual mechanismsC-H Chen, W-H Chang, K-Y Su, W-H Ku, G-C Chang, Q-S Hong, Y-J Hsiao, H-C Chen, H-Y Chen, R Wu, P-C Yang, J J W Chen and S-L Yu Oncogene 2016 35: 5674-5685; advance online publication, April 11, 2016; 10.1038/onc.2016.106 Abstract | Full Text |  | Short Communications | Top |  | Transformation of human CD34+ hematopoietic progenitor cells with DEK-NUP214 induces AML in an immunocompromised mouse modelH Qin, S Malek, J K Cowell and M Ren Oncogene 2016 35: 5686-5691; advance online publication, April 11, 2016; 10.1038/onc.2016.118 Abstract | Full Text |  |  |  | ERK1/2-induced phosphorylation of R-Ras GTPases stimulates their oncogenic potentialC Frémin, J-P Guégan, C Plutoni, J Mahaffey, M R Philips, G Emery and S Meloche Oncogene 2016 35: 5692-5698; advance online publication, April 18, 2016; 10.1038/onc.2016.122 Abstract | Full Text |  |  |  |  |  |  |  |  |  |  | Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.
Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com |  |  |  |  |  | |  | Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. |  | | | | |
No comments:
Post a Comment